Fig. 2From: Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysisResults of the PSA with 1000 random iterations on the cost-effectiveness plane showing the expected savings (€) and QALY gains in the whole reached population (n = 180,774). The results of the intervention have been shown over a timeframe of 10, 20, and 30 years. The point estimate is presented with a yellow color dotBack to article page